Comparison of Vancomycin AUC24 Calculation Methods for Neonates and Infants

被引:0
|
作者
Laitila, Tuomas [1 ]
Sankilampi, Ulla [2 ,3 ]
Renko, Marjo [2 ,3 ]
Kokki, Merja [4 ]
Ranta, Veli-Pekka [5 ]
机构
[1] Kuopio Univ Hosp Pharm, Kuopio, Finland
[2] Kuopio Univ Hosp, Dept Pediat, Kuopio, Finland
[3] Univ Eastern Finland, Inst Clin Med, Kuopio, Finland
[4] Kuopio Univ Hosp, Dept Anaesthesiol & Intens Care, Kuopio, Finland
[5] Univ Eastern Finland, Sch Pharm, Yliopistonranta 1 C, Kuopio 70210, Finland
关键词
REGIMENS;
D O I
10.1007/s13318-024-00920-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and ObjectiveFor neonates and infants receiving intermittent vancomycin infusions, the area under the concentration-time curve during 24 h (AUC24) is often estimated with Bayesian forecasting using one or more measured vancomycin concentrations. When practical peak and trough concentrations are measured at steady state, AUC24 can also be calculated with first-order steady-state equations for a one-compartment model (Sawchuk-Zaske method), but previously this method has been applied only for adults. The objective of this study was to compare AUC24 values obtained with the Sawchuk-Zaske method and two Bayesian models.MethodsAUC24 values were estimated retrospectively for 18 neonates and infants with steady-state peak and trough concentrations using traditional compartmental analysis with a one-compartment model (reference method), the Sawchuk-Zaske method, and Bayesian forecasting with two previously published models. In Bayesian forecasting, both original and modified residual error models were used. In the modified models, the residual error was reduced by setting the additive residual error to zero and the proportional error to 15%.ResultsAUC24 estimates obtained with the Sawchuk-Zaske method differed - 2.7 to 0.9% from the reference method. When both peak and trough concentrations were used in Bayesian forecasting, 61% and 33% of AUC24 estimates obtained with two original models differed less than 15% from the reference method, and these fractions increased to 83% and 72% with the modified models, respectively.ConclusionWhen practical peak and trough concentrations are measured at steady state, the simple Sawchuk-Zaske method is very useful for AUC24 estimation in neonates and infants. In Bayesian forecasting, the reduced residual error model can be used to improve the model fit.
引用
收藏
页码:773 / 779
页数:7
相关论文
共 50 条
  • [21] VANCOMYCIN PHARMACOKINETICS IN NEONATES AND INFANTS - A RETROSPECTIVE EVALUATION
    ASBURY, WH
    DARSEY, EH
    ROSE, WB
    MURPHY, JE
    BUFFINGTON, DE
    CAPERS, CC
    ANNALS OF PHARMACOTHERAPY, 1993, 27 (04) : 490 - 496
  • [22] Evaluation of the Association between Trough and Area Under the Curve to Minimum Inhibitory Concentration Ratio (AUC24/MIC) of Vancomycin in Infected Patients with Methicillin Resistant Staphylococcus aureus (MRSA)
    Esmaeili, Ayda
    Salehi, Mohammadreza
    Makhdomi, Nava
    Ardakani, Yalda H.
    Rajabi, Mehdi
    Namazi, Soha
    PHARMACEUTICAL SCIENCES, 2021, 27 (02) : 201 - 208
  • [23] Vancomycin AUC0-24 estimation using first-order pharmacokinetic methods in pediatric patients
    Brandon, Hope H.
    Burgess, David S.
    Wallace, Katie L.
    Autry, Elizabeth B.
    Olney, Katie B.
    PHARMACOTHERAPY, 2024, 44 (04): : 294 - 300
  • [24] A comparison of methods to predict drug clearance in neonates, infants and children
    Johnson, TN
    Rostami-Hodjegan, A
    Tucker, GT
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (05) : 677 - 678
  • [25] Prediction of Area Under the Curve of Vancomycin in Infants: A Comparison of Two Methods
    Gogtay, Nithya J.
    Bavdekar, Sandeep B.
    INDIAN JOURNAL OF PEDIATRICS, 2020, 87 (05): : 331 - 332
  • [26] Prediction of Area Under the Curve of Vancomycin in Infants: A Comparison of Two Methods
    Nithya J Gogtay
    Sandeep B Bavdekar
    The Indian Journal of Pediatrics, 2020, 87 : 331 - 332
  • [27] Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children
    Rodvold, KA
    Everett, JA
    Pryka, RD
    Kraus, DM
    CLINICAL PHARMACOKINETICS, 1997, 33 (01) : 32 - 51
  • [28] Index for the appropriate vancomycin dosing in premature neonates and infants
    Endo, Aiju
    Nemoto, Atsushi
    Hanawa, Kazumi
    Ishikawa, Takahiro
    Koshiishi, Mai
    Maebayashi, Yuki
    Hasebe, Yohei
    Naito, Atsushi
    Kobayashi, Yoshifumi
    Isobe, Katsuhiko
    Kawano, Yayoi
    Hanawa, Takehisa
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [29] Predictive Value of Vancomycin AUC24/MIC Ratio for 30-day Mortality in Patients with Severe or Complicated Methicillin-Resistant Staphylococcus aureus Infections: A Multicenter Retrospective Study
    Hanai, Yuki
    Hashi, Hideki
    Hanawa, Kazumi
    Endo, Aiju
    Miyazaki, Taito
    Yamaguchi, Tetsuo
    Harada, Sohei
    Yokoo, Takuya
    Uekusa, Shusuke
    Namiki, Takaya
    Yokoyama, Yoshiaki
    Asakawa, Daiki
    Isoda, Ryo
    Enoki, Yuki
    Taguchi, Kazuaki
    Matsumoto, Kazuaki
    Matsuo, Kazuhiro
    PHARMACEUTICAL RESEARCH, 2024, 41 (07) : 1381 - 1389
  • [30] Pharmacokinetics and Administration Regimens of Vancomycin in Neonates, Infants and Children
    Keith A. Rodvold
    Julie A. Everett
    Randy D. Pryka
    Donna M. Kraus
    Clinical Pharmacokinetics, 1997, 33 : 32 - 51